Daniel Arias
Stock Analyst at Stifel
(5.00)
# 9
Out of 4,896 analysts
154
Total ratings
55.06%
Success rate
148.65%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BRKR Bruker | Maintains: Hold | $57 → $48 | $43.21 | +11.09% | 8 | May 8, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $52.62 | +14.03% | 11 | May 8, 2025 | |
| GH Guardant Health | Maintains: Buy | $53 → $60 | $49.77 | +20.55% | 3 | May 1, 2025 | |
| AVTR Avantor | Downgrades: Hold | $26 → $14 | $13.22 | +5.90% | 9 | Apr 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $425.34 | +45.77% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $197.75 | +31.48% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $2.25 | +300.89% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $12.47 | +44.35% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $6.73 | -10.85% | 2 | Nov 13, 2024 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,550 → $1,450 | $1,193.89 | +21.45% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $57.82 | +12.42% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $54.30 | +23.39% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $304.18 | +18.35% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $120.08 | +25.75% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $48.28 | -4.00% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.67 | +274.53% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $121.33 | +70.61% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $95 → $110 | $98.47 | +11.71% | 1 | Feb 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $98.53 | +102.98% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $3.08 | +62.34% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $2.66 | +275.94% | 2 | May 31, 2022 |
Bruker
May 8, 2025
Maintains: Hold
Price Target: $57 → $48
Current: $43.21
Upside: +11.09%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $52.62
Upside: +14.03%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $53 → $60
Current: $49.77
Upside: +20.55%
Avantor
Apr 28, 2025
Downgrades: Hold
Price Target: $26 → $14
Current: $13.22
Upside: +5.90%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $425.34
Upside: +45.77%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $197.75
Upside: +31.48%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.25
Upside: +300.89%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $12.47
Upside: +44.35%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $6.73
Upside: -10.85%
Mettler-Toledo International
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,193.89
Upside: +21.45%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $57.82
Upside: +12.42%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $54.30
Upside: +23.39%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $304.18
Upside: +18.35%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $120.08
Upside: +25.75%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $48.28
Upside: -4.00%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $2.67
Upside: +274.53%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $121.33
Upside: +70.61%
Feb 2, 2024
Maintains: Hold
Price Target: $95 → $110
Current: $98.47
Upside: +11.71%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $98.53
Upside: +102.98%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $3.08
Upside: +62.34%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $2.66
Upside: +275.94%